Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral tolerance mechanisms are essential for their regulation. We report the role of proinsulin (PI) expression on the development and activation of insulin-specific CTLs in the NOD mouse model of type 1 diabetes. We studied insulin B-chain–specific CTL from different T-cell receptor transgenic mice (G9Cα−/−) expressing normal PI1 and PI2 or altered PI expression levels. In the absence of PI2 (Ins2−/−), CTL in pancreatic lymph nodes (PLNs) were more activated, and male G9Cα−/− mice developed T1D. Furthermore, when the insulin-specific CTLs developed in transgenic mice lacking their specific PI epitope, the CTLs demonstrated increased cytotoxicity and...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Type 1 diabetes (T1D) results from T-cell-mediated autoimmune destruction of pancreatic β cells. Eff...
Type 1 diabetes (T1D) results from T-cell-mediated autoimmune destruction of pancreatic β cells. Eff...
Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral to...
Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral to...
Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral to...
Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral to...
Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral to...
NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, ...
NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, ...
NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, ...
NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, ...
NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, ...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Type 1 diabetes (T1D) results from T-cell-mediated autoimmune destruction of pancreatic β cells. Eff...
Type 1 diabetes (T1D) results from T-cell-mediated autoimmune destruction of pancreatic β cells. Eff...
Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral to...
Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral to...
Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral to...
Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral to...
Low-avidity autoreactive CD8 T cells (CTLs) escape from thymic negative selection, and peripheral to...
NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, ...
NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, ...
NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, ...
NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, ...
NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, ...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Type 1 diabetes (T1D) results from T-cell-mediated autoimmune destruction of pancreatic β cells. Eff...
Type 1 diabetes (T1D) results from T-cell-mediated autoimmune destruction of pancreatic β cells. Eff...